Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
CMC Biologics
CMC Biologics
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
CMC Biologics to manufacture bispecific antibodies for F-star
Supporting F-star’s strong pipeline development in immuno-oncology
Manufacturing
CMC Biologics and IDT Biologika collaborate to manufacture antibody drug conjugates
Alliance will provide an efficient end-to-end solution for the development and manufacture of ADCs
Research & Development
CMC Biologics and PATH MVI to develop monoclonal antibodies to treat malaria
Manufacture of monoclonal antibodies to the malaria parasite scheduled for CMC’s Berkeley, US, facility
Manufacturing
CMC Biologics expands GMP manufacturing capacity in the US
Bioreactor 6Pack facility provides flexible solutions for Phase III and commercial production
Manufacturing
CMC Biologics adds capacity to GMP manufacturing facility in Denmark
Bioreactor 6Pack facility design provides flexible solutions for Phase III and commercial production
Manufacturing
CMC Biologics makes two appointments
Mark Sawicki and Patricio Massera join the CRO
Manufacturing
CMC Biologics and Inspiration agree supply of IB1001
For the treatment and prevention of bleeding in haemophilia B patients
Subscribe now